This study is a double-blind, randomized, parallel group comparison of the effects of FX006 and Triamcinolone Acetonide Injectable Suspension, USP (referred to as TCA IR in the protocol) on blood glucose in patients with osteoarthritis of the knee and Type 2 diabetes mellitus.